SHANGHAI & CAMBRIDGE, Mass., April 23, 2025--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that updated data from an ongoing, global Phase 1a/1b clinical trial (NCT06179069 ...

In a report released today, Louise Chen from Scotiabank maintained a Buy rating on Zai Lab (ZLAB – Research Report), with a price target of $55.00. The company’s shares closed last Friday at ...

Zai Lab Limited Unsponsored ADR (ZLAB) shares soared 21.5% in the last trading session to close at $29.54. The move was backed by solid volume with far more shares changing hands than in a normal ...

Fintel reports that on March 7, 2025, Scotiabank initiated coverage of Zai Lab Limited - Depositary Receipt () (NasdaqGM:ZLAB) with a Sector Outperform recommendation. As of March 4, 2025 ...